Filing Details
- Accession Number:
- 0001209191-22-006383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-02 16:32:42
- Reporting Period:
- 2022-01-31
- Accepted Time:
- 2022-02-02 16:32:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1764157 | A. Elizabeth Barrett | 400 Alexander Park Drive Princeton NJ 08540 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-01-31 | 5,000 | $0.00 | 303,220 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-01-31 | 2,235 | $7.58 | 300,985 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2022-01-31 | 13,333 | $0.00 | 314,318 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-01-31 | 5,960 | $7.58 | 308,358 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2022-01-31 | 5,000 | $0.00 | 5,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2022-01-31 | 13,333 | $0.00 | 13,333 | $0.00 |
| Ordinary Shares | Stock Option (right to buy) | Acquisiton | 2022-01-31 | 150,000 | $0.00 | 150,000 | $7.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | No | 4 | M | Direct | ||
| 26,667 | No | 4 | M | Direct | ||
| 150,000 | 2032-01-31 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
- Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
- The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021.
- The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022.
- 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025
Billionaire Hedge Funds
